M 444
Pill imprint M 444 has been identified as Benazepril hydrochloride 20 mg.
Benazepril is used in the treatment of high blood pressure; diabetic kidney disease; heart failure; left ventricular dysfunction and belongs to the drug class angiotensin converting enzyme inhibitors. There is positive evidence of human fetal risk during pregnancy.
Benazepril 20 mg is not subject to the Controlled Substances Act.
See also related documents.
Benazepril hydrochloride Images
- Imprint:
-
M 444
- Strength:
- 20 mg
- Color:
- White
- Size:
- 9.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- lactose anhydrous
silicon dioxide colloidal
crospovidone
hypromellose
polydextrose
polyethylene glycol
pregelatinized starch
stearic acid
magnesium silicate
titanium dioxide
triacetin
- Drug Class:
- Angiotensin converting enzyme inhibitors
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-0444
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0146 | UDL Laboratories Inc |
Note: Inactive ingredients may vary.
Advertisement
More Benazepril Hydrochloride resources
- Benazepril (Wolters Kluwer)
- benazepril (Cerner Multum)
- benazepril (Micromedex) - Includes Dosage Information
- Benazepril Hydrochloride (AHFS DI)
- Benazepril (FDA)
- Benazepril Hydrochloride (Wolters Kluwer)
Search Again
